Nifty

:

14433.70

Sensex

:

49034.67

-161.90 (-1.11%)
-549.49 (-1.11%)

Login

Nifty
Sensex

:
:

14433.70
49034.67

-161.90 (-1.11%)
-549.49 (-1.11%)

RPG Life Sciences Ltd.

Pharmaceuticals & Drugs - Global

Rating :

64/99

BSE: 532983 | NSE: RPGLIFE

Watchlist

NSE BSE

367.50

15-Jan-2021

Open
High
Low
Previous Close

374.85
374.85
365.45
372.10

Volume
Traded Value (lacs)
52 Week High
52 Week Low

36715
135.41
429.00
142.95

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

608.55
19.57
8

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

619.16
1.09%
3.09

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.23
6.10
2.98

EBITDA CAGR (%)

10 Years
5 Years
3 Years

6.29
21.85
10.08

PAT CAGR (%)

10 Years
5 Years
3 Years

8.60
20.08
29.20

P:E (Median)

8 Years
5 Years
3 Years

26.42
31.66
23.98

P:BV (Average)

8 Years
5 Years
3 Years

2.76
2.76
2.76

EV:EBITDA (Average)

8 Years
5 Years
3 Years

41.97
16.55
12.08

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 97.13 98.49 -1.38% 91.65 94.04 -2.54% 88.67 68.80 28.88% 94.37 90.97 3.74%
Expenses 78.01 82.08 -4.96% 74.80 78.69 -4.94% 76.17 62.25 22.36% 79.48 78.89 0.75%
EBITDA 19.12 16.41 16.51% 16.85 15.35 9.77% 12.50 6.55 90.84% 14.89 12.08 23.26%
EBIDTM 19.68% 16.66% 18.39% 16.32% -0.29% -0.29% 15.78% 13.28%
Other Income 0.04 0.15 -73.33% 0.45 0.16 181.25% 0.38 0.42 -9.52% 0.04 0.02 100.00%
Interest 0.23 0.36 -36.11% 0.31 0.73 -57.53% 0.30 0.91 -67.03% 0.36 0.99 -63.64%
Depreciation 4.20 4.16 0.96% 4.16 3.92 6.12% 4.12 3.94 4.57% 4.16 3.86 7.77%
PBT 14.73 12.04 22.34% 12.83 10.86 18.14% 3.14 2.12 48.11% 10.41 7.25 43.59%
Tax 3.58 2.27 57.71% 3.77 2.51 50.20% 0.16 0.58 -72.41% 2.50 1.97 26.90%
PAT 11.15 9.77 14.12% 9.06 8.35 8.50% 2.98 1.54 93.51% 7.91 5.28 49.81%
PATM 11.48% 9.92% 9.89% 8.88% 2.87% 2.87% 8.38% 5.80%
EPS 6.76 5.92 14.19% 5.49 5.06 8.50% 1.81 0.93 94.62% 4.79 3.20 49.69%

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 371.82 375.57 330.16 343.95 293.64 279.32 242.27 235.55 221.64 192.82 186.83 Net Sales Growth 5.54% 13.75% -4.01% 17.13% 5.13% 15.29% 2.85% 6.28% 14.95% 3.21% Cost Of Goods Sold 591.26 119.63 103.93 106.87 96.02 84.94 77.17 69.44 68.94 48.44 49.72 Gross Profit -219.44 255.94 226.23 237.08 197.62 194.38 165.10 166.11 152.70 144.38 137.11 GP Margin -59.02% 68.15% 68.52% 68.93% 67.30% 69.59% 68.15% 70.52% 68.90% 74.88% 73.39% Total Expenditure 308.46 315.67 295.73 306.89 265.01 257.02 233.76 224.38 206.01 174.67 154.28 Power & Fuel Cost - 11.54 10.38 10.44 9.10 11.23 10.76 10.29 8.76 7.23 6.61 % Of Sales - 3.07% 3.14% 3.04% 3.10% 4.02% 4.44% 4.37% 3.95% 3.75% 3.54% Employee Cost - 95.90 89.93 90.14 75.59 74.13 68.66 62.18 55.20 49.99 40.24 % Of Sales - 25.53% 27.24% 26.21% 25.74% 26.54% 28.34% 26.40% 24.91% 25.93% 21.54% Manufacturing Exp. - 21.85 18.98 21.86 20.63 26.88 23.61 24.59 24.23 21.78 13.53 % Of Sales - 5.82% 5.75% 6.36% 7.03% 9.62% 9.75% 10.44% 10.93% 11.30% 7.24% General & Admin Exp. - 32.76 34.32 35.76 31.57 24.58 21.81 23.67 21.64 20.88 20.84 % Of Sales - 8.72% 10.39% 10.40% 10.75% 8.80% 9.00% 10.05% 9.76% 10.83% 11.15% Selling & Distn. Exp. - 20.13 18.61 22.51 17.90 16.44 11.42 12.19 12.05 11.69 11.36 % Of Sales - 5.36% 5.64% 6.54% 6.10% 5.89% 4.71% 5.18% 5.44% 6.06% 6.08% Miscellaneous Exp. - 13.86 19.58 19.31 14.20 18.82 20.33 22.02 15.19 14.66 11.36 % Of Sales - 3.69% 5.93% 5.61% 4.84% 6.74% 8.39% 9.35% 6.85% 7.60% 6.41% EBITDA 63.36 59.90 34.43 37.06 28.63 22.30 8.51 11.17 15.63 18.15 32.55 EBITDA Margin 17.04% 15.95% 10.43% 10.77% 9.75% 7.98% 3.51% 4.74% 7.05% 9.41% 17.42% Other Income 0.91 0.99 0.80 2.36 9.78 1.96 6.57 2.87 2.25 0.69 0.72 Interest 1.20 2.76 4.86 4.72 3.64 2.49 2.72 2.60 7.47 6.88 6.28 Depreciation 16.64 16.36 15.32 14.34 11.31 10.15 11.36 10.61 9.87 10.22 9.52 PBT 41.11 41.77 15.05 20.36 23.46 11.62 1.00 0.83 0.54 1.74 17.47 Tax 10.01 7.44 4.24 6.91 2.45 0.00 0.00 11.57 -3.87 0.89 4.76 Tax Rate 24.35% 20.41% 28.17% 33.94% 10.44% 0.00% 0.00% 17.81% -716.67% 51.15% 27.25% PAT 31.10 29.01 10.81 13.45 21.01 11.62 1.00 53.40 4.41 0.85 12.71 PAT before Minority Interest 31.10 29.01 10.81 13.45 21.01 11.62 1.00 53.40 4.41 0.85 12.71 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 8.36% 7.72% 3.27% 3.91% 7.16% 4.16% 0.41% 22.67% 1.99% 0.44% 6.80% PAT Growth 24.70% 168.36% -19.63% -35.98% 80.81% 1,062.00% -98.13% 1,110.88% 418.82% -93.31% EPS 18.85 17.58 6.55 8.15 12.73 7.04 0.61 32.36 2.67 0.52 7.70

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 176.57 160.50 154.75 147.01 133.59 125.16 125.76 76.23 74.14 74.83 Share Capital 13.23 13.23 13.23 13.23 13.23 13.23 13.23 13.23 13.23 13.23 Total Reserves 163.34 147.27 141.52 133.78 120.36 111.93 112.53 63.00 60.91 61.60 Non-Current Liabilities 8.75 9.58 8.37 10.77 22.45 19.93 6.54 22.16 42.35 38.58 Secured Loans 0.22 4.63 10.11 15.89 0.13 0.17 0.30 10.37 16.11 18.88 Unsecured Loans 1.30 1.95 0.12 0.16 0.11 0.15 0.06 0.15 4.56 5.92 Long Term Provisions 8.50 6.19 2.79 2.32 19.60 16.95 1.42 5.55 7.65 0.76 Current Liabilities 82.59 77.82 120.71 78.68 66.80 67.19 76.51 111.67 72.51 82.69 Trade Payables 44.41 25.13 51.87 28.65 33.71 25.30 37.02 47.43 28.87 39.85 Other Current Liabilities 20.30 13.32 18.47 14.91 10.17 6.64 5.19 24.01 16.88 11.08 Short Term Borrowings 5.12 29.04 37.92 24.01 21.96 32.46 13.68 37.09 24.39 20.34 Short Term Provisions 12.76 10.33 12.45 11.11 0.96 2.79 20.62 3.14 2.37 11.42 Total Liabilities 267.91 247.90 283.83 236.46 222.84 212.28 208.81 210.06 189.00 196.10 Net Block 122.89 127.64 130.80 136.67 109.26 104.52 106.05 102.92 108.69 112.50 Gross Block 173.81 162.55 150.65 142.43 189.83 175.51 166.93 153.94 152.15 146.06 Accumulated Depreciation 50.92 34.91 19.85 5.76 80.57 70.99 60.88 51.02 43.46 33.56 Non Current Assets 142.13 150.81 141.21 140.08 135.65 126.18 112.05 110.75 119.63 115.94 Capital Work in Progress 9.98 17.17 8.73 1.82 1.59 0.72 0.84 1.26 1.28 0.25 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 9.26 6.00 1.68 1.59 24.80 20.94 5.16 6.57 9.66 3.19 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 125.78 97.09 142.62 96.38 87.19 86.10 96.76 99.31 69.37 80.16 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 46.61 41.04 53.69 45.78 39.02 34.48 37.77 29.37 28.79 26.31 Sundry Debtors 63.33 38.90 68.13 39.28 36.99 40.61 36.34 49.29 30.09 38.35 Cash & Bank 1.11 0.77 0.94 1.60 0.80 0.72 0.70 0.78 0.56 0.48 Other Current Assets 14.73 6.93 7.60 5.59 10.38 10.29 21.95 19.87 9.93 15.02 Short Term Loans & Adv. 6.51 9.45 12.26 4.13 9.80 10.29 21.95 11.46 9.93 15.02 Net Current Assets 43.19 19.27 21.91 17.70 20.39 18.91 20.25 -12.36 -3.14 -2.53 Total Assets 267.91 247.90 283.83 236.46 222.84 212.28 208.81 210.06 189.00 196.10

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 50.17 45.78 14.68 7.33 32.81 -1.97 -5.56 12.32 15.62 14.42 PBT 36.45 15.05 20.36 23.46 11.62 1.00 64.97 0.54 1.74 17.47 Adjustment 22.52 20.08 17.37 6.95 12.64 7.39 -45.77 16.85 16.31 15.07 Changes in Working Capital -2.37 14.37 -19.35 -18.81 10.92 -6.47 -14.06 -4.68 -0.57 -14.42 Cash after chg. in Working capital 56.60 49.50 18.38 11.60 35.18 1.92 5.14 12.71 17.48 18.12 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -6.43 -3.72 -3.70 -4.27 -2.37 -3.89 -10.70 -0.39 -1.86 -3.70 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -10.70 -19.02 -15.54 -30.06 -15.25 -10.31 59.30 -12.13 -7.83 -12.83 Net Fixed Assets -4.07 -20.34 -15.13 47.17 -15.19 -8.46 -12.57 -1.77 -7.12 -10.85 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -6.63 1.32 -0.41 -77.23 -0.06 -1.85 71.87 -10.36 -0.71 -1.98 Cash from Financing Activity -39.30 -26.50 0.11 23.36 -17.58 12.24 -53.65 -0.19 -7.75 -1.91 Net Cash Inflow / Outflow 0.17 0.26 -0.75 0.63 -0.02 -0.04 0.09 0.00 0.04 -0.32 Opening Cash & Equivalents 0.37 0.11 0.86 0.23 0.25 0.29 0.20 0.20 0.16 0.80 Closing Cash & Equivalent 0.54 0.37 0.11 0.86 0.23 0.25 0.29 0.20 0.20 0.48

Financial Ratios

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 106.77 97.05 93.58 88.89 80.78 75.68 76.05 46.10 44.83 45.25 ROA 11.25% 4.07% 5.17% 9.15% 5.34% 0.47% 25.50% 2.21% 0.44% 6.95% ROE 17.21% 6.86% 8.91% 14.98% 8.98% 0.80% 52.87% 5.87% 1.14% 18.37% ROCE 20.35% 9.81% 12.52% 15.58% 8.97% 2.49% 48.37% 5.99% 6.73% 19.70% Fixed Asset Turnover 2.23 2.11 2.37 1.85 1.59 1.47 1.52 1.50 1.34 1.38 Receivable days 49.68 59.16 56.47 45.37 48.80 55.80 63.90 63.14 62.69 66.26 Inventory Days 42.59 52.36 52.29 50.44 46.22 52.39 50.10 46.26 50.47 39.24 Payable days 43.27 56.38 53.51 47.24 47.03 55.90 77.54 78.01 82.51 101.36 Cash Conversion Cycle 48.99 55.15 55.25 48.57 47.99 52.29 36.47 31.38 30.66 4.14 Total Debt/Equity 0.07 0.23 0.35 0.30 0.17 0.27 0.12 0.83 0.73 0.71 Interest Cover 14.21 4.10 5.31 7.45 5.67 1.37 25.99 1.07 1.25 3.78

Top Investors:

authum investment and infrastructure limited

Annual Reports:

News Update:

RPG Life Sciences - Quarterly Results
30th Oct 2020, 17:24 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback